The IFC wants venture capitalists to take a close look at these opportunities

 Nikunj Jinsi, global head of the International Finance Corporation’s venture capital group at the Emerging Markets Venture Forum. Photo by: Kenny Schick

“I sell drugs in Africa,” Gregory Rockson, co-founder and chief executive officer of mPharma, said to a room of Silicon Valley investors.

The Ghana-based founder of the e-prescription startup, who wore a dark sweater with a gold print of Africa growing from roots, grabbed the attention of the venture capitalists before pitching his opportunity. The value of pharmaceutical spending in Africa will reach $45 billion by 2020, he said.

This article is for Devex Members

For full access to the content of the article sign in or join Devex.

About the author

  • Cheney catherine%2520%25281%2529

    Catherine Cheney

    Catherine Cheney is a Senior Reporter for Devex. She covers the West Coast of the U.S., focusing on the role of technology and innovation in achieving the Sustainable Development Goals. And she frequently represents Devex as a speaker and moderator. Prior to joining Devex, Catherine earned her bachelor’s and master’s degrees from Yale University, worked as a web producer for POLITICO and reporter for World Politics Review, and helped to launch NationSwell. Catherine has reported from all over the world, and freelanced for outlets including the Atlantic and the Washington Post. She is also the West Coast ambassador for the Solutions Journalism Network, a nonprofit that trains and connects journalists to cover responses to problems.